Patriot Financial Group Insurance Agency’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,205
Closed -$13K 956
2022
Q2
$13K Hold
1,205
﹤0.01% 1153
2022
Q1
$11K Hold
1,205
﹤0.01% 1312
2021
Q4
$14K Hold
1,205
﹤0.01% 1346
2021
Q3
$12K Buy
1,205
+525
+77% +$5.37K ﹤0.01% 1393
2021
Q2
$7K Buy
680
+150
+28% +$1.46K ﹤0.01% 1554
2021
Q1
$5K Buy
530
+200
+61% +$3.1K ﹤0.01% 1551
2020
Q4
$8K Buy
+330
New +$6.75K ﹤0.01% 1290

Other funds holding FOLD

Patriot Financial Group Insurance Agency's FOLD Position: Q3 2022 in Review

Patriot Financial Group Insurance Agency sold out of Amicus Therapeutics (FOLD) in Q3 2022, closing a stake of 1,205 shares — an estimated $13K sold.

Patriot Financial Group Insurance Agency first reported a position in FOLD in Q4 2020 and held it in 7 quarters. The position peaked at $14K in Q4 2021. 222 funds tracked by Wall St. Rank hold FOLD as of Q3 2022.

  • Patriot Financial Group Insurance Agency reported no remaining Amicus Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 1,205 Amicus Therapeutics shares in Q3 2022, an estimated $13K.
  • Patriot Financial Group Insurance Agency first reported a position in Amicus Therapeutics in Q4 2020 and held it in 7 quarters.
  • Patriot Financial Group Insurance Agency's Amicus Therapeutics position peaked at $14K in Q4 2021.
  • 222 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2022, filed 1 Nov 2022.